Watson Says Barr Infringes Patent For Oxytrol
Watson Laboratories Inc. has slapped generic drug manufacturer Barr Pharmaceuticals Inc. with a patent infringement lawsuit over its application to market a generic version of Oxytrol, an overactive bladder treatment....To view the full article, register now.
Already a subscriber? Click here to view full article